The World’s Longest-Standing, Industry-Leading Touchpoint for the Precision Medicine Ecosystem
The precision medicine field is evolving at lightning speed, from liquid biopsy-driven MRD detection and high‑plex single‑cell and multi‑omic profiling to breakthroughs in digital pathology, spatial analytics, and next‑generation IVD assays. This year’s upcoming 16th World Clinical Biomarkers & Companion Diagnostics Summit is an unmissable opportunity to uncover the latest translational case studies, global regulatory shifts, and integrated commercialization strategies redefining how biomarkers power drug development, clinical decision‑making, and scalable personalized care.
A Snapshot of Unmissable Agenda Highlights
Bolster Biomarker Discovery & Validation
Uncover cutting-edge progress in genomic sequencing, ctDNA, and MRD biomarkers, empowering earlier detection and real-time disease monitoring
Implement Novel Technologies & Trials
Charter the integration of omics and AI-driven biomarker strategies advancing early detection and personalized therapies across high-burden indications
Pioneer Digital & AI-Enabled Innovations
Discover the workflows, models and adoption strategies behind scalable and physician appropriate digital and computational pathology innovations
Optimize Drug-Diagnostic Co-Development
Explore the initiation, scale-up and regulatory responsibilities of co-development partnerships to spark compliant and scalable strategic alliances
Streamline CDx Development & Commercialization
Discover fit-for-purpose CDx strategies that mitigate testing disparities, reduce clinical setbacks, and strengthen therapeutic development
Navigate IVDR Adherence
Cast your attention to the expectations of global regulatory and notified bodies to streamline harmonized drug-diagnostic compliance and approvals worldwide
Register Your Interest for 2026
- Free* to Attend for Biopharma & Academia
- The Globally Leading Biomarker & Companion Diagnostic Forum
- Strategic Rx-Dx Co-Development & Partnership Selection Panels
- Biomarker Panels in Oncology, Hematology, Neurological, Chronic, Autoimmune, & Rare Disease
- Brand-New Case Studies on Digital Pathology, Multimodal Data and AI-Enabled Precision Medicine
- Exclusive Networking & Partnerships Opportunities
Attending Companies Included
Explore the New Agenda
Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients
Prioritize Partnering with Us
Take up a partnering slot to stand alongside leading biomarker, diagnostic and technology providers, ensure your brand is front and center, and retain your position as the partner of choice in the ever-expanding precision medicine space
Join 850+ Specialist Experts
Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations